Pharmaceutical companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under 2 spellings of its name, each linked to the record.
As of Nov 21, 2026, FDA's public records list Romark Laboratories with 3 drug applications and 1 drug recall. The most recent is a drug recall dated Apr 24, 2015: Alinia (nitazoxanide), powder for oral suspension, 100mg/5mL, 60 mL/bottle. Rx only, Man….
| Apr 24, 2015 | Alinia (nitazoxanide), powder for oral suspension, 100mg/5mL, 60 mL/bottle. Rx only, Manufactured for Lupin Pharmaceuticals Inc, Baltimore…Class II · Failed Stability Specifications: Product failed to meet 12 months long term stability specification for viscosity | Drug recall |
| Jun 16, 2005 | AliniaNDA 21818 | Drug application |
| Jul 21, 2004 | AliniaNDA 21497 | Drug application |
| Nov 22, 2002 | AliniaNDA 21498 | Drug application |
What this company reported paying US doctors and teaching hospitals each year, $22.2M of it for research; see every company
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.